5-year recurrence risk | Type and stage | Time interval to transplant |
Low risk <5% risk of recurrence | Stage IA/IB, grade 1 to 2 endometrial cancer without lymph-vascular space invasion | No waiting period after completion of primary treatment |
Stage IA/IB/IC grade 1 to 2 epithelial ovarian cancer | ||
Stage IA1, IA2 squamous/adenocarcinoma of the cervix | ||
Intermediate risk 5 to 15% risk of recurrence | Stage I/II endometrial cancer +risk factors* | 2 to 3 years after completion of treatment |
Stage IB squamous/adenocarcinoma of the cervix | ||
High risk >30% risk of recurrence | Serous, clear cell, or carcinosarcoma of uterus (all stages) | 5 years after completion of treatment |
Stage III grade 1 to 3 endometrioid cancer of the uterus | ||
Stage II/III epithelial ovarian cancer | ||
Stage II/III squamous cell/adenocarcinoma cervical cancer | ||
Very high risk >80% risk of recurrence | Stage IV endometrial cancer (all grades) | Not a SOT candidate |
Recurrent or metastatic endometrial cancer | ||
Stage IV epithelial ovarian cancer (any grade) | ||
Recurrent ovarian cancer | ||
Stage IV squamous cell/adenocarcinoma of the cervix | ||
Metastatic or recurrent cervical cancer |
Do you want to add Medilib to your home screen?